ArticleEuropean heart journal open2026
Population-level cardiovascular risk prediction models including biochemical predictors in 800 000 individuals.
Article in European heart journal open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Most countries lack the clinical cohort data required to create cardiovascular disease (CVD) risk prediction models and rely on models developed elsewhere. However, individual-person linkage of health administrative databases enables the creation of local models. Objectives: This study aimed to explore whether the addition of routine biochemical tests could improve the performance of 'administrative data-based' models. Methods and results: Estimated glomerular filtration rate, haemoglobin A1c, total cholesterol/high-density lipoprotein cholesterol ratio, and triglyceride tests performed on one-third of New Zealand adults were identified and linked to national administrative health datasets (11 564 665 tests). Sex-specific Cox models estimating 5-year CVD in people aged 30-74 without prior CVD were developed, internally and temporally validated, and compared, including and excluding the four biochemical predictors. 805 817 individuals were included, of whom 64% had all four examined test results available. 1.8% of women and 3.4% of men experienced a CVD event during 4.7 years mean follow-up. All biochemical predictors except triglyceride level in men were statistically significant independent predictors of CVD risk. The addition of these predictors improved global model performance metrics over models without biochemical predictors and identified 34% of men and 28% of women in the cohort who accounted for 75% of all CVD events, respectively. Conclusion: Biochemical predictors improved the performance of administrative data-based CVD risk prediction models, illustrating the untapped potential of widely available databases. Similar models could be developed in many countries and healthcare organizations if health administrative databases were linked. These models could be remotely applied across populations to inform CVD prevention policy and practices. Condensed abstract: Novel CVD risk prediction models have recently been developed in New Zealand and Denmark from predictors available in health administrative data, but their performance is limited by their parsimony. Biochemical predictors are now linkable to New Zealand administrative datasets and we show that they improve the predictive ability of previous 'administrative data-based' models. These new models were remotely deployed across a large New Zealand region, identifying 27% of individuals who accounted for 74% of subsequent CVD events. Similar models could be created in many countries and healthcare organizations to aid population health planning efforts, investigate equity gaps, and pre-screen populations who experience difficulties accessing traditional health services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.